Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Blood Transplantation for Hematologic Disorders
NCT00055653Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jan 2003
- Primary completion
- Sep 2003
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in leukemia, lymphoma, myelodysplastic syndrome (MDS), aplastic anemia, Fanconi anemia (FA), sponsored by Roswell Park Comprehensive Cancer Center. Started Jan 2003; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
leukemialymphomamyelodysplastic syndrome (MDS)aplastic anemiaFanconi anemia (FA)
Beyond the preview
Go deeper on NCT00055653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055653.